Gradual Reduction in RRNA Transcription Triggers P53 Acetylation and Apoptosis Via MYBBP1A

Overview

Journal Sci Rep

Specialty Science

Date 2015 Jun 6

PMID 26044764

Citations 17

Authors

Takuya Kumazawa

Kazuho Nishimura

Naohiro Katagiri

Sayaka Hashimoto

Yuki Hayashi

Keiji Kimura

Affiliations

Soon will be listed here.

Abstract

The nucleolus, whose primary function is ribosome biogenesis, plays an essential role in p53 activation. Ribosome biogenesis is inhibited in response to cellular stress and several nucleolar proteins translocate from the nucleolus to the nucleoplasm, where they activate p53. In this study, we analysed precisely how impaired ribosome biogenesis regulates the activation of p53 by depleting nucleolar factors involved in rRNA transcription or rRNA processing. Nucleolar RNA content decreased when rRNA transcription was inhibited. In parallel with the reduced levels of nucleolar RNA content, the nucleolar protein Myb-binding protein 1 A (MYBBP1A) translocated to the nucleoplasm and increased p53 acetylation. The acetylated p53 enhanced p21 and BAX expression and induced apoptosis. In contrast, when rRNA processing was inhibited, MYBBP1A remained in the nucleolus and nonacetylated p53 accumulated, causing cell cycle arrest at the G1 phase by inducing p21 but not BAX. We propose that the nucleolus functions as a stress sensor to modulate p53 protein levels and its acetylation status, determining cell fate between cell cycle arrest and apoptosis by regulating MYBBP1A translocation.

Citing Articles

Aptamer AS411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer.

Zhu Y, Li X, Zhang Q, Yang X, Sun X, Pan Y RSC Med Chem. 2024; 15(5):1515-1526.

PMID: 38784467 PMC: 11110790. DOI: 10.1039/d3md00752a.

NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53/IRF1/type I interferon signaling axis.

Wang Z, Luo J, Huang H, Wang L, Lv T, Wang Z Cell Death Discov. 2024; 10(1):240.

PMID: 38762546 PMC: 11102450. DOI: 10.1038/s41420-024-01997-2.

The role of protein acetylation in carcinogenesis and targeted drug discovery.

Yang J, Song C, Zhan X Front Endocrinol (Lausanne). 2022; 13:972312.

PMID: 36171897 PMC: 9510633. DOI: 10.3389/fendo.2022.972312.

Historical museum samples enable the examination of divergent and parallel evolution during invasion.

Stuart K, Sherwin W, Austin J, Bateson M, Eens M, Brandley M Mol Ecol. 2022; 31(6):1836-1852.

PMID: 35038768 PMC: 9305591. DOI: 10.1111/mec.16353.

p38-MAPK-mediated translation regulation during early blastocyst development is required for primitive endoderm differentiation in mice.

Bora P, Gahurova L, Masek T, Hauserova A, Potesil D, Jansova D Commun Biol. 2021; 4(1):788.

PMID: 34172827 PMC: 8233355. DOI: 10.1038/s42003-021-02290-z.

References

Espinosa J . Mechanisms of regulatory diversity within the p53 transcriptional network. Oncogene. 2008; 27(29):4013-23. PMC: 2914794. DOI: 10.1038/onc.2008.37. View

Carter S, Vousden K . Modifications of p53: competing for the lysines. Curr Opin Genet Dev. 2009; 19(1):18-24. DOI: 10.1016/j.gde.2008.11.010. View

Vousden K, Prives C . Blinded by the Light: The Growing Complexity of p53. Cell. 2009; 137(3):413-31. DOI: 10.1016/j.cell.2009.04.037. View

Kruse J, Gu W . Modes of p53 regulation. Cell. 2009; 137(4):609-22. PMC: 3737742. DOI: 10.1016/j.cell.2009.04.050. View

Zhu Y, Poyurovsky M, Li Y, Biderman L, Stahl J, Jacq X . Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell. 2009; 35(3):316-26. PMC: 2896961. DOI: 10.1016/j.molcel.2009.07.014. View

Hoppe S, Bierhoff H, Cado I, Weber A, Tiebe M, Grummt I . AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply. Proc Natl Acad Sci U S A. 2009; 106(42):17781-6. PMC: 2764937. DOI: 10.1073/pnas.0909873106. View

Zhang Y, Lu H . Signaling to p53: ribosomal proteins find their way. Cancer Cell. 2009; 16(5):369-77. PMC: 4369769. DOI: 10.1016/j.ccr.2009.09.024. View

Lee J, Gu W . The multiple levels of regulation by p53 ubiquitination. Cell Death Differ. 2009; 17(1):86-92. PMC: 3690487. DOI: 10.1038/cdd.2009.77. View

Holzel M, Orban M, Hochstatter J, Rohrmoser M, Harasim T, Malamoussi A . Defects in 18 S or 28 S rRNA processing activate the p53 pathway. J Biol Chem. 2010; 285(9):6364-70. PMC: 2825431. DOI: 10.1074/jbc.M109.054734. View

10.

Burger K, Muhl B, Harasim T, Rohrmoser M, Malamoussi A, Orban M . Chemotherapeutic drugs inhibit ribosome biogenesis at various levels. J Biol Chem. 2010; 285(16):12416-25. PMC: 2852979. DOI: 10.1074/jbc.M109.074211. View

11.

Schlereth K, Beinoraviciute-Kellner R, Zeitlinger M, Bretz A, Sauer M, Charles J . DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell. 2010; 38(3):356-68. DOI: 10.1016/j.molcel.2010.02.037. View

12.

McMahon M, Ayllon V, Panov K, OConnor R . Ribosomal 18 S RNA processing by the IGF-I-responsive WDR3 protein is integrated with p53 function in cancer cell proliferation. J Biol Chem. 2010; 285(24):18309-18. PMC: 2881756. DOI: 10.1074/jbc.M110.108555. View

13.

Lai P, Chi T, Chen G . Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro. Apoptosis. 2006; 12(2):387-93. DOI: 10.1007/s10495-006-0571-1. View

14.

Taira N, Nihira K, Yamaguchi T, Miki Y, Yoshida K . DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Mol Cell. 2007; 25(5):725-38. DOI: 10.1016/j.molcel.2007.02.007. View

15.

Vousden K, Lane D . p53 in health and disease. Nat Rev Mol Cell Biol. 2007; 8(4):275-83. DOI: 10.1038/nrm2147. View

16.

Kruhlak M, Crouch E, Orlov M, Montano C, Gorski S, Nussenzweig A . The ATM repair pathway inhibits RNA polymerase I transcription in response to chromosome breaks. Nature. 2007; 447(7145):730-4. DOI: 10.1038/nature05842. View

17.

Tanaka T, Ohkubo S, Tatsuno I, Prives C . hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes. Cell. 2007; 130(4):638-50. DOI: 10.1016/j.cell.2007.08.001. View

18.

Chen Z, Knutson E, Wang S, Martinez L, Albrecht T . Stabilization of p53 in human cytomegalovirus-initiated cells is associated with sequestration of HDM2 and decreased p53 ubiquitination. J Biol Chem. 2007; 282(40):29284-95. DOI: 10.1074/jbc.M705349200. View

19.

Beckerman R, Prives C . Transcriptional regulation by p53. Cold Spring Harb Perspect Biol. 2010; 2(8):a000935. PMC: 2908772. DOI: 10.1101/cshperspect.a000935. View

20.

Castle C, Cassimere E, Lee J, Denicourt C . Las1L is a nucleolar protein required for cell proliferation and ribosome biogenesis. Mol Cell Biol. 2010; 30(18):4404-14. PMC: 2937536. DOI: 10.1128/MCB.00358-10. View